Zhang Z - Search Results

1

Improving tumor hypoxia and radiotherapy resistance via in situ nitric oxide release strategy.

Tu J, Tu K, Xu H, Wang L, Yuan X, Qin X, Kong L, Chu Q, Zhang Z. Tu J, et al. Among authors: zhang z. Eur J Pharm Biopharm. 2020 May;150:96-107. doi: 10.1016/j.ejpb.2020.03.003. Epub 2020 Mar 6. Eur J Pharm Biopharm. 2020. PMID: 32151726

2

Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance.

Guo Y, Chu M, Tan S, Zhao S, Liu H, Otieno BO, Yang X, Xu C, Zhang Z. Guo Y, et al. Among authors: zhang z. Mol Pharm. 2014 Jan 6;11(1):59-70. doi: 10.1021/mp400514t. Epub 2013 Nov 21. Mol Pharm. 2014. PMID: 24229050

3

D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells.

Bao Y, Guo Y, Zhuang X, Li D, Cheng B, Tan S, Zhang Z. Bao Y, et al. Among authors: zhang z. Mol Pharm. 2014 Sep 2;11(9):3196-209. doi: 10.1021/mp500384d. Epub 2014 Aug 14. Mol Pharm. 2014. PMID: 25102234

4

Nitric oxide releasing d-α-tocopheryl polyethylene glycol succinate for enhancing antitumor activity of doxorubicin.

Song Q, Tan S, Zhuang X, Guo Y, Zhao Y, Wu T, Ye Q, Si L, Zhang Z. Song Q, et al. Among authors: zhang z. Mol Pharm. 2014 Nov 3;11(11):4118-29. doi: 10.1021/mp5003009. Epub 2014 Sep 29. Mol Pharm. 2014. PMID: 25222114

5

D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery.

Wu Y, Chu Q, Tan S, Zhuang X, Bao Y, Wu T, Zhang Z. Wu Y, et al. Among authors: zhang z. Int J Nanomedicine. 2015 Aug 20;10:5219-35. doi: 10.2147/IJN.S82847. eCollection 2015. Int J Nanomedicine. 2015. PMID: 26316751 Free PMC article.

6

A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery.

Bao Y, Yin M, Hu X, Zhuang X, Sun Y, Guo Y, Tan S, Zhang Z. Bao Y, et al. Among authors: zhang z. J Control Release. 2016 Aug 10;235:182-194. doi: 10.1016/j.jconrel.2016.06.003. Epub 2016 Jun 2. J Control Release. 2016. PMID: 27264552

7

Enhanced tumor therapy via drug co-delivery and in situ vascular-promoting strategy.

Yin M, Tan S, Bao Y, Zhang Z. Yin M, et al. Among authors: zhang z. J Control Release. 2017 Jul 28;258:108-120. doi: 10.1016/j.jconrel.2017.05.016. Epub 2017 May 15. J Control Release. 2017. PMID: 28522191

8

Biomimetic Nanovesicles for Enhanced Antitumor Activity of Combinational Photothermal and Chemotherapy.

Wu T, Zhang D, Qiao Q, Qin X, Yang C, Kong M, Deng H, Zhang Z. Wu T, et al. Among authors: zhang d, zhang z. Mol Pharm. 2018 Mar 5;15(3):1341-1352. doi: 10.1021/acs.molpharmaceut.7b01142. Epub 2018 Feb 9. Mol Pharm. 2018. PMID: 29397741

9

Micelle System Based on Molecular Economy Principle for Overcoming Multidrug Resistance and Inhibiting Metastasis.

Qi Y, Qin X, Yang C, Wu T, Qiao Q, Song Q, Zhang Z. Qi Y, et al. Among authors: zhang z. Mol Pharm. 2018 Mar 5;15(3):1005-1016. doi: 10.1021/acs.molpharmaceut.7b00922. Epub 2018 Feb 9. Mol Pharm. 2018. PMID: 29397749

10

A facile doxorubicin-dichloroacetate conjugate nanomedicine with high drug loading for safe drug delivery.

Yang C, Wu T, Qin Y, Qi Y, Sun Y, Kong M, Jiang X, Qin X, Shen Y, Zhang Z. Yang C, et al. Among authors: zhang z. Int J Nanomedicine. 2018 Mar 6;13:1281-1293. doi: 10.2147/IJN.S154361. eCollection 2018. Int J Nanomedicine. 2018. PMID: 29563787 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

112,167 results

Search Page

Filters